News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Cellectricon strengthens its presence in Japan

MÖLNDAL, SWEDEN Cellectricon is pleased to announce a strategic collaboration with Biosector and Stefan Sandström, aimed at strengthening the company’s...

February 24-26, 2026

Bio-Neuroscience

The Bio-Neuroscience meeting takes place in Amsterdam, the Netherlands on February 24-26. The meeting brings together leading CEOs, investors, executives...

February 3-5, 2026

Alzheimer’s & Parkinson’s Drug Development Summit

The Alzheimer’s & Parkinson’s Drug Development Summit takes place in Boston, US on February 3-5. The meeting brings together experts...

Sign up to get news & events updates from Cellectricon

January 27-29, 2026

Non-Opioid Pain Therapeutics Summit

The Non-Opioid Pain Therapeutics Summit takes place in Boston, US on January 27-29. The meeting brings together experts in pain...

NEW DATE: January 22, 2026

Live webinar - A translationally relevant assay platform for assessment of acute onset antisense oligonucleotide-induced neurotoxicity

This webinar takes place on Thursday January 22nd between 16.00 and 16.30 CET / 15.00-15.30 GMT / 10.00-10.30 AM EST / 7.00-7.30...

Cellectricon and CCRM Nordic announce strategic partnership

We are excited to announce a new collaboration with CCRM Nordic, the Nordic centre for advanced therapy medicinal products (ATMPs)....

Sign up to get news & events updates from Cellectricon

Cellectricon launches Neurotoxicity Testing Services

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of its new Neurotoxicity...

November 15-19, 2025

Neuroscience 2025

The Neuroscience 2025 meeting takes place in San Diego on November 15-19. During the conference, we will present several posters...

November 12, 2025

Live webinar - In vitro neuronal models for assessment of acute and delayed onset toxicity effects of oligonucleotide-based drugs

This webinar takes place on Wednesday November 12th between 16.00 and 16.30 CET / 10.00-10.30 AM EST / 7.00-7.30 AM PST.